Posttranslational Processing of Hepcidin in Human Hepatocytes is Mediated by the Prohormone Convertase Furin
Overview
Authors
Affiliations
Hepcidin is encoded as an 84 amino acid prepropeptide containing a typical N-terminal 24 amino acid endoplasmic reticulum targeting signal sequence, and a 35 amino acid proregion (pro) with a consensus furin cleavage site immediately followed by the C-terminal 25 amino acid bioactive iron-regulatory hormone (mature peptide). We performed pulse-chase studies of posttranslational processing of hepcidin in human hepatoma HepG2 cells and in primary human hepatocytes induced with bone morphogenic protein (BMP-9). In some experiments, the cells were treated with the furin protease inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethylketone (CMK) or furin siRNA. In the absence of furin inhibitor, hepcidin was found to be processed in less than 1 h and secreted as a 3 kDa form reactive with anti-mature but not anti-pro antibody. In the presence of furin inhibitors or furin siRNA, a 6 kDa form reactive with both anti-pro and anti-mature antibody was rapidly secreted into the medium. Processing was not affected by inhibitors of the hypoxia inducible factor (HIF) pathway, or by treatment with 30 microM holo- or apo-transferrin. In conclusion, the hepatic prohormone convertase furin mediates the posttranslational processing of hepcidin. The proteolytic cleavage of prohepcidin to hepcidin is not regulated by iron-transferrin or the HIF pathway.
Anju M, Archana K, Musthafa S, Anooja V, Athira P, Neelima S Mar Biotechnol (NY). 2025; 27(2):52.
PMID: 39969620 DOI: 10.1007/s10126-025-10426-z.
Suh S, Oh T, Choi H, Kim C, Bae E, Ma S Kidney Dis (Basel). 2024; 10(6):492-503.
PMID: 39664339 PMC: 11631166. DOI: 10.1159/000542057.
Wang X, Lenartowicz M, Mazgaj R, Ogluszka M, Szkopek D, Zaworski K Int J Mol Sci. 2024; 25(20).
PMID: 39456997 PMC: 11508764. DOI: 10.3390/ijms252011215.
Social defeat stress impairs systemic iron metabolism by activating the hepcidin-ferroportin axis.
Kasahara E, Nakamura A, Morimoto K, Ito S, Hori M, Sekiyama A FASEB Bioadv. 2024; 6(8):263-275.
PMID: 39114446 PMC: 11301257. DOI: 10.1096/fba.2024-00071.
Iron metabolism and ferroptosis in nonalcoholic fatty liver disease: what is our next step?.
Shen X, Yu Z, Wei C, Hu C, Chen J Am J Physiol Endocrinol Metab. 2024; 326(6):E767-E775.
PMID: 38506752 PMC: 11376490. DOI: 10.1152/ajpendo.00260.2023.